CIAM
PRCT icon

Caitong International Asset Management’s Procept Biorobotics PRCT Stock Holding History

Caitong International Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5K Sell
1,438
-1,121
-44% -$28.1K ﹤0.01% 837
2026
Q1 		$64K Buy
2,559
+1,413
+123% +$39.8K 0.01% 704
2025
Q4 		$36.1K Buy
1,146
+975
+570% +$32.3K 0.01% 825
2025
Q3 		$6.1K Buy
171
+160
+1,455% +$7.31K ﹤0.01% 1169
2025
Q2 		$634 Sell
11
-23
-68% -$1.3K ﹤0.01% 1665
2025
Q1 		$1.98K Buy
+34
New +$2.32K ﹤0.01% 1351

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caitong International Asset Management's PRCT Position: Q2 2026 in Review

Caitong International Asset Management reduced its Procept Biorobotics (PRCT) stake by 44% in Q2 2026, selling an estimated $28.1K and leaving 1,438 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Caitong International Asset Management first reported a position in PRCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $64K in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Caitong International Asset Management held 1,438 shares of Procept Biorobotics worth $32.5K as of Q2 2026.
  • Caitong International Asset Management sold 1,121 Procept Biorobotics shares in Q2 2026, an estimated $28.1K.
  • Procept Biorobotics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #837 holding.
  • Caitong International Asset Management first reported a position in Procept Biorobotics in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Procept Biorobotics position peaked at $64K in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.